Related Experiment Video
Updated: May 7, 2026

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Erasmus syndrome: silicosis and systemic sclerosis
Revista Brasileira De Reumatologia
|September 21, 2013
Summary
Silicosis, an irreversible lung fibrosis from silica dust, is linked to autoimmune diseases. Two silicosis patients developed systemic sclerosis, highlighting this association.
Area of Science:
- Occupational Medicine
- Pulmonary Medicine
- Rheumatology
Background:
- Silicosis is a prevalent pneumoconiosis caused by inhaling silica or silicate dust, leading to irreversible lung fibrosis.
- Silica exposure is associated with increased risks of tuberculosis, lung cancer, and autoimmune diseases.
- Connective tissue diseases typically manifest 15 years post-initial silica exposure.
Observation:
- The Erasmus syndrome describes systemic sclerosis following silica exposure, with or without silicosis.
- This report details two cases of patients diagnosed with silicosis.
Findings:
- Both patients diagnosed with silicosis subsequently developed systemic sclerosis.
- This observation supports the link between silicosis and the development of systemic sclerosis.
Implications:
- These cases underscore the importance of recognizing systemic sclerosis as a potential complication in individuals with silicosis.
- Increased awareness and monitoring for autoimmune conditions in silica-exposed populations are warranted.
- Further research into the pathogenesis of silica-induced autoimmune diseases is needed.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

